MET (NYSE: MET) Form 144 lists recent Common Stock sale notices, including 562 shares

Rhea-AI Filing Summary

MetLife (MET) reported proposed sales of Common Stock under a Form 144 filing. The notice lists multiple transactions dated between 12/17/2025 and 01/09/2026, with example recent sales including 562 shares on 01/09/2026 and 359 shares on 12/19/2025.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Wells Fargo 500 W 33rd St New York NY 10001	725	52250.75	652053867	03/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	12/19/2014	Purchase	GOLDMAN SACHS			434	12/24/2014	Cash
Common Stock	12/31/2014	Purchase	GOLDMAN SACHS			291	01/06/2015	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	12/17/2025	231	19064.43
Separate Account 149 1 Metlife Way Whippany NJ 07981	Common Stock	12/19/2025	10	815.7
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	12/19/2025	38	3099.66
Separate Account SPI 1 Metlife Way Whippany NJ 07981	Common Stock	12/19/2025	137	11175.09
MetLife 401k Plan Russell 1000 Value 1 Metlife Way Whippany NJ 07981	Common Stock	12/19/2025	68	5546.76
MetLife 401k Plan Trust-Large Cap Equity Index 1 Metlife Way Whippany NJ 07981	Common Stock	12/19/2025	359	29283.63
Separate Account SPI 1 Metlife Way Whippany NJ 07981	Common Stock	01/09/2026	562	44628.42

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the MET Form 144 disclose?

It discloses proposed sales of Common Stock by holders. The filing lists transactions dated 12/17/2025 through 01/09/2026, with individual sale sizes shown for each entry.

How many shares did MetLife-related accounts sell on 01/09/2026 in the filing?

The filing shows a sale of 562 shares on 01/09/2026. This entry is listed under Separate Account SPI with a proceeds/value column recorded in the excerpt.

Which recent sale sizes are listed for MET in December 2025?

Examples include 359 shares on 12/19/2025 and 231 shares on 12/17/2025. Multiple account entries on 12/19/2025 show other smaller lots.

Do the entries name the broker or sale method?

Some entries list a broker for older transactions (e.g., GOLDMAN SACHS) and list Purchase type for those dates. Recent entries show account names but not explicit sale methods in the excerpt.

Are these sales part of an ongoing plan or one-off transactions?

The excerpt lists discrete transaction dates and account names but does not state a sale program or plan. The filing shows individual proposed sales on specific dates only.